Evaluation of Inhaled Colistin/Fosfomycin as an Adjunctive Treatment for Ventilator-Associated Pneumonia: A Preliminary Study.

Health Sci Rep · 2025 · PMC12715318 · PMID 41424677

Europe PMC DOI

hedged sentence

0.2300

closest p · 4.6× alpha

0.2300

boldest claim

The sentences

did not reach statistical significancep = 0.23not close (p > 0.1)

The colistin/fosfomycin group exhibited a higher microbiological response rate ( n = 19; 48.7%) than the colistin group ( n = 13; 35.1%), although the difference did not reach statistical significance ( p = 0.23).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.